Standardizing Supplement Recommendations in a Neuro-Oncology Clinic: A Pharmacist-Led Quality Improvement Initiative

Patients with primary brain tumors frequently use supplements and repurposed drugs alongside standard treatments. However, inconsistent counseling practices, variable provider knowledge, and limited evidence-based guidance contribute to fragmented recommendations, potential drug-supplement interactions, and adverse events.